Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Juan Pelaez; Investor Relations; Linde PLC. Sanjiv Lamba; Chief Executive Officer, Director; Linde PLC. Matthew White; Chief Financial Officer, Executive Vice Presid ...

These value stocks can offer stability and upside potential, making them solid anchors for your portfolio amid market ...

Despite short-term headwinds due to customer warehouse overbuilds, we believe the pandemic only accelerated the need for automation given the strong secular trend toward e-commerce. Many of ...

Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.

Offering these ideas as a negotiating tactic to reach an intermediate goal isn’t Trump’s style. He means it when he says it.

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

In the 1950s, a Melbourne accountant named Rees Withers gathered a small band of explorers to start looking for oil in Victoria’s Gippsland region.

Solar-heated homes integrate thermal energy storage, improving efficiency and reducing environmental impact through ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Innovation UBC announced 10 new startup ventures joining their HATCH Venture Builder Winter 2025 cohort (HATCH). HATCH is a ...